Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dina Visca and Rosella Centis.
Dina Visca
Connection Strength
1.870
Rosella Centis
  1. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. J Bras Pneumol. 2021; 47(4):e20210076.
    View in: PubMed
    Score: 0.239
  2. The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia. Arch Bronconeumol (Engl Ed). 2021 Jun 17.
    View in: PubMed
    Score: 0.238
  3. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021 Mar-Apr; 27(2):151-165.
    View in: PubMed
    Score: 0.231
  4. Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients. Pulmonology. 2021 Sep-Oct; 27(5):452-455.
    View in: PubMed
    Score: 0.231
  5. Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis. J Asthma. 2020 12; 57(12):1365-1371.
    View in: PubMed
    Score: 0.209
  6. Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019 03; 53(3).
    View in: PubMed
    Score: 0.203
  7. Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 2021 May-Jun; 27(3):248-256.
    View in: PubMed
    Score: 0.058
  8. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Front Med (Lausanne). 2020; 7:572485.
    View in: PubMed
    Score: 0.057
  9. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
    View in: PubMed
    Score: 0.057
  10. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.056
  11. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020 Jul - Aug; 26(4):233-240.
    View in: PubMed
    Score: 0.055
  12. Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. Eur Respir J. 2018 07; 52(1).
    View in: PubMed
    Score: 0.048
  13. Tuberculosis elimination: where are we now? Eur Respir Rev. 2018 Jun 30; 27(148).
    View in: PubMed
    Score: 0.048
  14. Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management. Curr Opin Pulm Med. 2018 05; 24(3):244-252.
    View in: PubMed
    Score: 0.048
  15. Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico. Eur Respir J. 2018 03; 51(3).
    View in: PubMed
    Score: 0.048
  16. World TB Day 2017: Strengthening the fight against TB. Presse Med. 2017 Mar; 46(2 Pt 2):e1-e4.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.